Richard Newitter
Stock Analyst at Truist Securities
(4.15)
# 448
Out of 4,945 analysts
379
Total ratings
49.34%
Success rate
13.54%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings | Downgrades: Hold | $111 → $63 | $53.85 | +16.99% | 19 | Aug 12, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Hold | $190 → $125 | $84.18 | +48.49% | 26 | Aug 5, 2025 | |
| SYK Stryker | Maintains: Hold | $410 → $415 | $376.27 | +10.29% | 21 | Aug 4, 2025 | |
| BBNX Beta Bionics | Maintains: Buy | $18 → $21 | $14.79 | +41.99% | 2 | Jul 30, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $145 → $137 | $107.39 | +27.57% | 8 | Jul 25, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $81 → $82 | $77.30 | +6.08% | 19 | Jul 25, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $120 → $125 | $102.71 | +21.70% | 17 | Jul 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $590 → $600 | $475.68 | +26.14% | 29 | Jul 23, 2025 | |
| TNDM Tandem Diabetes Care | Initiates: Hold | $24 | $10.96 | +118.98% | 1 | Jun 16, 2025 | |
| DXCM DexCom | Initiates: Buy | $102 | $79.11 | +28.93% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $365 | $308.71 | +18.23% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $80 → $68 | $60.81 | +11.83% | 27 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $121.36 | +12.89% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $140 → $135 | $89.82 | +50.30% | 5 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $70 | $39.29 | +78.16% | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $51 | $36.00 | +41.67% | 3 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $9.5 → $8 | $6.73 | +18.87% | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $93 → $90 | $92.39 | -2.59% | 15 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $24 | $19.01 | +26.25% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $19 | $13.49 | +40.85% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $111 → $145 | $163.65 | -11.40% | 16 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $101.89 | +10.90% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $285 | $255.00 | +11.76% | 5 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $15.38 | +36.59% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $8.09 | +147.22% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $85.95 | -4.60% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $194.78 | +28.35% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $4.77 | +445.65% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $142.86 | +438.99% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $68.32 | +24.41% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $12.70 | +57.48% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $14.46 | +86.72% | 5 | Feb 23, 2021 |
Lantheus Holdings
Aug 12, 2025
Downgrades: Hold
Price Target: $111 → $63
Current: $53.85
Upside: +16.99%
Inspire Medical Systems
Aug 5, 2025
Downgrades: Hold
Price Target: $190 → $125
Current: $84.18
Upside: +48.49%
Stryker
Aug 4, 2025
Maintains: Hold
Price Target: $410 → $415
Current: $376.27
Upside: +10.29%
Beta Bionics
Jul 30, 2025
Maintains: Buy
Price Target: $18 → $21
Current: $14.79
Upside: +41.99%
Integer Holdings
Jul 25, 2025
Maintains: Buy
Price Target: $145 → $137
Current: $107.39
Upside: +27.57%
Edwards Lifesciences
Jul 25, 2025
Maintains: Hold
Price Target: $81 → $82
Current: $77.30
Upside: +6.08%
Boston Scientific
Jul 24, 2025
Maintains: Buy
Price Target: $120 → $125
Current: $102.71
Upside: +21.70%
Intuitive Surgical
Jul 23, 2025
Maintains: Buy
Price Target: $590 → $600
Current: $475.68
Upside: +26.14%
Tandem Diabetes Care
Jun 16, 2025
Initiates: Hold
Price Target: $24
Current: $10.96
Upside: +118.98%
DexCom
Jun 16, 2025
Initiates: Buy
Price Target: $102
Current: $79.11
Upside: +28.93%
Jun 16, 2025
Initiates: Buy
Price Target: $365
Current: $308.71
Upside: +18.23%
May 12, 2025
Maintains: Hold
Price Target: $80 → $68
Current: $60.81
Upside: +11.83%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $121.36
Upside: +12.89%
May 1, 2025
Reiterates: Buy
Price Target: $140 → $135
Current: $89.82
Upside: +50.30%
Apr 11, 2025
Maintains: Buy
Price Target: $90 → $70
Current: $39.29
Upside: +78.16%
Apr 11, 2025
Maintains: Buy
Price Target: $61 → $51
Current: $36.00
Upside: +41.67%
Apr 11, 2025
Maintains: Hold
Price Target: $9.5 → $8
Current: $6.73
Upside: +18.87%
Apr 11, 2025
Maintains: Hold
Price Target: $93 → $90
Current: $92.39
Upside: -2.59%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $19.01
Upside: +26.25%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $19
Current: $13.49
Upside: +40.85%
Feb 21, 2025
Maintains: Buy
Price Target: $111 → $145
Current: $163.65
Upside: -11.40%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $101.89
Upside: +10.90%
Dec 18, 2024
Maintains: Buy
Price Target: $240 → $285
Current: $255.00
Upside: +11.76%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $15.38
Upside: +36.59%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $8.09
Upside: +147.22%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $85.95
Upside: -4.60%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $194.78
Upside: +28.35%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $4.77
Upside: +445.65%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $142.86
Upside: +438.99%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $68.32
Upside: +24.41%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $12.70
Upside: +57.48%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $14.46
Upside: +86.72%